There are no shortcuts to real, lasting change
Crackers, toast, ginger chews, or a handful of almonds can settle the stomach without adding significant volume
they make healthy habits more sustainable by reducing the constant hunger that derails so many attempts
To ask questions or schedule a consultation with Dr Mary Colman, please use this link: Spotlight: Dr
GLP-1 microdosing aligns with this philosophy by: Shifting from Reactive to Proactive Care Instead of waiting for full-blown diabetes or obesity to develop, microdosing allows us to intervene upstream, potentially preventing disease progression before it fully takes hold
Future GLP-1 trends: new drugs and therapies on the horizon The future of weight management may soon involve more than current GLP-1s: Amylin mimetics: These compounds mimic another satiety hormone and may complement GLP-1s. Mazdutide: A dual glucagon/GLP-1 agonist showing strong Phase 3 results and promising greater weight loss. Oral GLP-1s: Pills in development could improve convenience. Muscle-preserving combinations: Researchers are exploring co-therapies to prevent loss of lean mass during weight loss. Providers should prepare for a rapidly evolving landscape and educate patients about upcoming options. Key takeaways on GLP-1 trends for providers and patients Efficacy varies across drugs and doses
